Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
Background Since the release of the first global hepatitis elimination targets in 2016, and
until the COVID-19 pandemic started in early 2020, many countries and territories were …
until the COVID-19 pandemic started in early 2020, many countries and territories were …
Global epidemiology of chronic liver disease
S Cheemerla, M Balakrishnan - Clinical liver disease, 2021 - journals.lww.com
Cirrhosis is a leading cause of mortality and morbidity across the world. It is the 11th leading
cause of death and 15th leading cause of morbidity, accounting for 2.2% of deaths and 1.5 …
cause of death and 15th leading cause of morbidity, accounting for 2.2% of deaths and 1.5 …
[HTML][HTML] Global, regional and national burden of primary liver cancer by subtype
Introduction Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA)
are the two main histological subtypes of primary liver cancer. Estimates of the burden of …
are the two main histological subtypes of primary liver cancer. Estimates of the burden of …
Contemporary epidemiology of chronic liver disease and cirrhosis
Background & Aims Accurate estimates for the contemporary burden of chronic liver disease
(CLD) are vital for setting clinical, research, and policy priorities. We aimed to review the …
(CLD) are vital for setting clinical, research, and policy priorities. We aimed to review the …
Current epidemiology in hepatocellular carcinoma
P Konyn, A Ahmed, D Kim - Expert review of gastroenterology & …, 2021 - Taylor & Francis
Introduction Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third-
leading cause of cancer-related mortality in the world. Areas covered This review will …
leading cause of cancer-related mortality in the world. Areas covered This review will …
Global reporting of progress towards elimination of hepatitis B and hepatitis C
Summary Background The 69th World Health Assembly endorsed the global health sector
strategy on viral hepatitis to eliminate viral hepatitis as a public health threat by 2030 …
strategy on viral hepatitis to eliminate viral hepatitis as a public health threat by 2030 …
EASL recommendations on treatment of hepatitis C: final update of the series☆
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
Updated epidemiology of gastrointestinal cancers in East Asia
Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence
and one-third of cancer-related mortality. Although there has been much progress in …
and one-third of cancer-related mortality. Although there has been much progress in …
Impact of COVID-19 on global HCV elimination efforts
Background & Aims Coronavirus disease 2019 (COVID-19) has placed a significant strain
on national healthcare systems at a critical moment in the context of hepatitis elimination …
on national healthcare systems at a critical moment in the context of hepatitis elimination …
Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies
The burden of liver disease in Europe continues to grow. We aimed to describe the
epidemiology of liver diseases and their risk factors in European countries, identifying public …
epidemiology of liver diseases and their risk factors in European countries, identifying public …